CTNNA1 and myeloid neoplasm: This suggests that CTNNA1 is a promising and essential tumor-suppressor gene involved in leukemic cell transformation, and then give a reasonable presumption that any biomedical procedure that could restore CTNNA1 expression represents a potential targeted therapeutic strategy to bring benefit to patients with myeloid malignancies.